{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:08:06Z","timestamp":1775218086742,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11655-018-2930-x","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T01:06:41Z","timestamp":1523581601000},"page":"806-808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Essence of \u201cShen (Kidney) Controlling Bones\u201d: Conceptual Analysis Based on Hypothalamic-Pituitary-Adrenal-Osteo-Related Cells Axis"],"prefix":"10.1007","volume":"24","author":[{"given":"Tao-tao","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-ting","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-jian","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"key":"2930_CR1","unstructured":"Malenka RC, Nestler EJ, Hyman SE eds. Neural and neuroendocrine control of the internal milieu. In: Molecular neuropharmacology: a foundation for clinical neuroscience. 2nd ed. New York: McGraw-Hill Medical, 246:248\u2013259."},{"key":"2930_CR2","doi-asserted-by":"publisher","first-page":"ITC17","DOI":"10.7326\/AITC201708010","volume":"167","author":"KE Ensrud","year":"2017","unstructured":"Ensrud KE, Crandall CJ. Osteoporosis. Ann Intern Med 2017;167:ITC17\u2013ITC32.","journal-title":"Ann Intern Med"},{"key":"2930_CR3","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","volume":"377","author":"TD Rachner","year":"2011","unstructured":"Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet 2011;377:1276\u20131287.","journal-title":"Lancet"},{"key":"2930_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/BF03401301","volume":"12","author":"K Aloumanis","year":"2013","unstructured":"Aloumanis K, Mavroudis K. The \"depressive\" face of osteoporosis and the \"osteoporotic\" face of depression. Hormones (Athens) 2013;12:350\u2013362.","journal-title":"Hormones (Athens)"},{"key":"2930_CR5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molmet.2017.02.003","volume":"6","author":"H Sasanuma","year":"2017","unstructured":"Sasanuma H, Nakata M, Parmila K, Nakae J, Yada T. PDK1-FoxO1 pathway in AgRP neurons of arcuate nucleus promotes bone formation via GHRH-GH-IGF1 axis. Mol Metab 2017;6:428\u2013439.","journal-title":"Mol Metab"},{"key":"2930_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrendo.2013.179","volume":"9","author":"SC Manolagas","year":"2013","unstructured":"Manolagas SC, O\u2019Brien CA, Almeida M. The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol 2013;9:699\u2013712.","journal-title":"Nat Rev Endocrinol"},{"key":"2930_CR7","doi-asserted-by":"publisher","first-page":"29851","DOI":"10.1074\/jbc.M112.377945","volume":"287","author":"M Onal","year":"2012","unstructured":"Onal M, Xiong J, Chen X, Thostenson JD, Almeida M, Manolagas SC, et al. Receptor activator of nuclear factor kappaB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. J Biol Chem 2012;287:29851\u201329860.","journal-title":"J Biol Chem"},{"key":"2930_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1210\/me.2009-0354","volume":"24","author":"M Martin-Millan","year":"2010","unstructured":"Martin-Millan M, Almeida M, Ambrogini E, Han L, Zhao H, Weinstein RS, et al. The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol 2010;24:323\u2013334.","journal-title":"Mol Endocrinol"},{"key":"2930_CR9","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00198-005-1840-5","volume":"16","author":"JM Koh","year":"2005","unstructured":"Koh JM, Khang YH, Jung CH, Bae S, Kim DJ, Chung YE, et al. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre-and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int 2005;16:1263\u20131271.","journal-title":"Osteoporos Int"},{"key":"2930_CR10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/jcb.22538","volume":"110","author":"S Jurado","year":"2010","unstructured":"Jurado S, Garcia-Giralt N, Diez-Perez A, Esbrit P, Yoskovitz G, Agueda L, et al. Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts. J Cell Biochem 2010;110:304\u2013310.","journal-title":"J Cell Biochem"},{"key":"2930_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/icb.2014.56","volume":"92","author":"LE Eades","year":"2014","unstructured":"Eades LE, Thiagarajah AS, Harris J, Jones SA, Morand EF, Leech M. GILZ: a new link between the hypothalamic pituitary adrenal axis and rheumatoid arthritis? Immunol Cell Biol 2014;92:747\u2013751.","journal-title":"Immunol Cell Biol"},{"key":"2930_CR12","first-page":"3","volume":"9","author":"A Beishuizen","year":"2003","unstructured":"Beishuizen A, Thijs LG. Endotoxin and the hypothalamopituitary-adrenal (HPA) axis. J Endotoxin Res 2003;9:3\u201324.","journal-title":"J Endotoxin Res"},{"key":"2930_CR13","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1210\/en.2003-1421","volume":"145","author":"MN Silverman","year":"2004","unstructured":"Silverman MN, Miller AH, Biron CA, Pearce BD. Characterization of an interleukin-6-and adrenocorticotropindependent, immune-to-adrenal pathway during viral infection. Endocrinology 2004;145:3580\u20133589.","journal-title":"Endocrinology"},{"key":"2930_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1749-6632.2009.04984.x","volume":"1179","author":"TW Pace","year":"2009","unstructured":"Pace TW, Miller AH. Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann N Y Acad Sci 2009;1179:86\u2013105.","journal-title":"Relevance to major depression. Ann N Y Acad Sci"},{"key":"2930_CR15","volume-title":"Chin J Integr Med","author":"YB Ren","year":"2015","unstructured":"Ren YB, Huang JH, Cai WJ, Shen ZY. Shen-Jing as a Chinese medicine concept might be a counterpart of stem cells in regenerative medicine. Chin J Integr Med 2015 Jul 4. Epub ahead print."},{"key":"2930_CR16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.stem.2017.01.002","volume":"20","author":"H Pierce","year":"2017","unstructured":"Pierce H, Zhang D, Magnon C, Lucas D, Christin JR, Huggins M, et al. Cholinergic signals from the CNS regulate G-CSF-mdiated HSC mobilization from bone marrow via a glucocorticoid signaling relay. Cell Stem Cell 2017;20:648\u2013658, e644.","journal-title":"Cell Stem Cell"},{"key":"2930_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.mehy.2012.09.001","volume":"79","author":"JF Evans","year":"2012","unstructured":"Evans JF, Ragolia L. Systemic and local ACTH produced during inflammatory states promotes osteochondrogenic mesenchymal cell differentiation contributing to the pathologic progression of calcified atherosclerosis. Med Hypotheses 2012;79:823\u2013826.","journal-title":"Med Hypotheses"},{"key":"2930_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1749-6632.2009.05231.x","volume":"1192","author":"CM Isales","year":"2010","unstructured":"Isales CM, Zaidi M, Blair HC. ACTH is a novel regulator of bone mass. Ann N Y Acad Sci 2010;1192:110\u2013116.","journal-title":"Ann N Y Acad Sci"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11655-018-2930-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-018-2930-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-018-2930-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T23:49:35Z","timestamp":1720223375000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11655-018-2930-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2930"],"URL":"https:\/\/doi.org\/10.1007\/s11655-018-2930-x","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,12]]},"assertion":[{"value":"20 December 2017","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}